Regulation of human flavin-containing monooxygenase 3 (FMO3) by D-element binding protein (DBP) and Yin Yang 1 (YY1)

被引：0
|
作者：
Klick, DE
Hines, RN
机构：
[1] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Pharmacol Toxicol, Milwaukee, WI 53226 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
402
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [21] In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles
    Cashman, JR
    Xiong, Y
    Lin, J
    Verhagen, H
    van Poppel, G
    van Bladeren, PJ
    Larsen-Su, S
    Williams, DE
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (06) : 1047 - 1055
  • [22] A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria
    Forrest, SM
    Knight, M
    Akerman, BR
    Cashman, JR
    Treacy, EP
    PHARMACOGENETICS, 2001, 11 (02): : 169 - 174
  • [23] Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication
    Treacy, EP
    Akerman, BR
    Chow, LML
    Youil, R
    Bibeau, C
    Lin, J
    Bruce, AG
    Knight, M
    Danks, DM
    Cashman, JR
    Forrest, SM
    HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 839 - 845
  • [24] Trimethylamine biosensor with flavin-containing monooxygenase type 3 (FMO3) for fish-freshness analysis
    Mitsubayashi, K
    Kubotera, Y
    Yano, K
    Hashimoto, Y
    Kon, T
    Nakakura, S
    Nishi, Y
    Endo, H
    SENSORS AND ACTUATORS B-CHEMICAL, 2004, 103 (1-2): : 463 - 467
  • [25] Non-synonymous genetic variants of flavin-containing monooxygenase 3 (FMO3) in cynomolgus macaques
    Uno, Yasuhiro
    Shimizu, Makiko
    Yoda, Hiromi
    Origuchi, Yumi
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : 104 - 107
  • [26] Trimethylamine N-oxygenation in cynomolgus macaques genotyped for flavin-containing monooxygenase 3 (FMO3)
    Shimizu, Makiko
    Uno, Yasuhiro
    Utoh, Masahiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (06) : 571 - 573
  • [27] A novel mutation in the flavin-containing monooxygenase 3 gene (FMO3) of a Norwegian family causes trimethylaminuria
    Allerston, C. K.
    Vetti, H. H.
    Houge, G.
    Phillips, I. R.
    Shephard, E. A.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 198 - 202
  • [28] GENETIC POLYMORPHISMS IN FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3) GENE RESPONSIBLE FOR TRIMETHYLAMINURIA IN A JAPANESE POPULATION
    Shimizu, Makiko
    Yamazaki, Hiroshi
    DRUG METABOLISM REVIEWS, 2015, 47 : 213 - 213
  • [29] ANALYSIS OF SUPPRESSION AND ACTIVATION OF THE HAPLOTYPED FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3) GENE TRANSCRIPTIONS IN JAPANESE
    Shimizu, Makiko
    Murayama, Norie
    Nagashima, Satomi
    Fujieda, Masaki
    Yamazaki, Hiroshi
    DRUG METABOLISM REVIEWS, 2008, 40 : 148 - 148
  • [30] Characterization of Human Flavin-Containing Monooxygenase (FMO) 3 and FMO5 Expressed as Maltose-Binding Protein Fusions
    Reddy, Robert R.
    Ralph, Erik C.
    Motika, Meike S.
    Zhang, Jun
    Cashman, John R.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (12) : 2239 - 2245
12345